RetinalGenix Technologies Inc (OTCPK:RTGN)
$ 3.5 0 (0%) Market Cap: 62.51 Mil Enterprise Value: 62.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

RetinalGenix Technologies Inc at Emerging Growth Conference Transcript

Oct 26, 2022 / 05:00PM GMT
Release Date Price: $12 (-40.00%)
Ana Berry
Emerging Growth Conference - Analyst

Yes, welcome back, everyone. Next up, we have RetinalGenix Technologies Inc. It trades on the OTCQB under the symbol, RTGN. It is a medical device company focused on preventing blindness through a cost-effective, mass-retinol clearing device and a patient real-time home monitoring imaging and physician alert system.

Jerry Katzman
RetinalGenix Technologies Inc. - Chairman, President & CEO

Good afternoon. Good afternoon, everyone. My name is Dr. Jerry Katzman. I'm the Chairman, President and CEO of the medtech company in Petaluma, California, known as RetinalGenix Technologies. And I'm here today to give you a short recap of what we've been doing since we actually are on the OTCQB.

It's very exciting. I'm going to just bring to your attention salient points, we have a very short period of time to do this, but I'm going to make some introductions also during this meeting. And I just want everyone to be aware of the team that we have.

So as a med tech company, as I said, we have three major

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot